Q

Qingdao NovelBeam Technology Co Ltd
SSE:688677

Watchlist Manager
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Watchlist
Price: 35.68 CNY -7.76% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Qingdao NovelBeam Technology Co Ltd?
Write Note

Qingdao NovelBeam Technology Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qingdao NovelBeam Technology Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Income from Continuing Operations
ÂĄ142.2m
CAGR 3-Years
14%
CAGR 5-Years
21%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Income from Continuing Operations
ÂĄ522.1m
CAGR 3-Years
71%
CAGR 5-Years
99%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Income from Continuing Operations
ÂĄ1.7B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Income from Continuing Operations
ÂĄ12.7B
CAGR 3-Years
19%
CAGR 5-Years
25%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Income from Continuing Operations
ÂĄ701.3m
CAGR 3-Years
-13%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Income from Continuing Operations
ÂĄ2B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Qingdao NovelBeam Technology Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Health Care

Qingdao NovelBeam Technology Co., Ltd. engages in the research and development of optics technology, the manufacture of optical instruments, and the provision of design solutions for medical, life science, laser, and micro-display projection applications. The company is headquartered in Qingdao, Shandong and currently employs 854 full-time employees. The company went IPO on 2021-02-26. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
56.99 CNY
Undervaluation 37%
Intrinsic Value
Price
Q

See Also

What is Qingdao NovelBeam Technology Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
142.2m CNY

Based on the financial report for Dec 31, 2023, Qingdao NovelBeam Technology Co Ltd's Income from Continuing Operations amounts to 142.2m CNY.

What is Qingdao NovelBeam Technology Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
21%

Over the last year, the Income from Continuing Operations growth was -22%. The average annual Income from Continuing Operations growth rates for Qingdao NovelBeam Technology Co Ltd have been 14% over the past three years , 21% over the past five years .

Back to Top